Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prediabetic State | 3 | 2018 | 65 | 1.210 |
Why?
|
| Hemangiosarcoma | 2 | 2018 | 9 | 1.210 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 1323 | 1.200 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 103 | 1.140 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 480 | 0.980 |
Why?
|
| Heart Failure | 4 | 2020 | 620 | 0.770 |
Why?
|
| Heart Neoplasms | 2 | 2018 | 18 | 0.740 |
Why?
|
| Electrocardiography | 3 | 2019 | 632 | 0.660 |
Why?
|
| Pulmonary Valve | 1 | 2018 | 11 | 0.630 |
Why?
|
| Aneurysm | 1 | 2018 | 21 | 0.630 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 24 | 0.630 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 27 | 0.630 |
Why?
|
| Teaching | 1 | 2018 | 61 | 0.590 |
Why?
|
| Myocardial Contraction | 2 | 2015 | 64 | 0.570 |
Why?
|
| Blood Glucose | 2 | 2018 | 491 | 0.550 |
Why?
|
| Contrast Media | 2 | 2015 | 138 | 0.510 |
Why?
|
| Gadolinium | 1 | 2015 | 22 | 0.500 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 16 | 0.500 |
Why?
|
| Clinical Competence | 1 | 2018 | 325 | 0.500 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2013 | 5 | 0.470 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 17 | 0.460 |
Why?
|
| Atherosclerosis | 2 | 2020 | 767 | 0.450 |
Why?
|
| Heart Ventricles | 1 | 2013 | 134 | 0.430 |
Why?
|
| Ethnic Groups | 1 | 2015 | 476 | 0.420 |
Why?
|
| Stroke Volume | 4 | 2020 | 341 | 0.410 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 398 | 0.380 |
Why?
|
| Humans | 18 | 2020 | 31836 | 0.360 |
Why?
|
| Aged | 11 | 2020 | 10288 | 0.340 |
Why?
|
| Systole | 2 | 2019 | 99 | 0.280 |
Why?
|
| Heart | 2 | 2018 | 178 | 0.270 |
Why?
|
| Male | 12 | 2020 | 19091 | 0.270 |
Why?
|
| Female | 12 | 2020 | 19859 | 0.270 |
Why?
|
| Risk Factors | 7 | 2020 | 3851 | 0.270 |
Why?
|
| Coronary Circulation | 2 | 2015 | 44 | 0.250 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 2271 | 0.240 |
Why?
|
| Middle Aged | 10 | 2020 | 11824 | 0.230 |
Why?
|
| Ventricular Function, Left | 2 | 2015 | 240 | 0.210 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 3988 | 0.200 |
Why?
|
| Kidney | 2 | 2019 | 515 | 0.200 |
Why?
|
| Risk Assessment | 3 | 2020 | 1431 | 0.170 |
Why?
|
| Language | 1 | 2019 | 42 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 92 | 0.160 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 80 | 0.160 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 125 | 0.160 |
Why?
|
| Brain Mapping | 1 | 2019 | 178 | 0.160 |
Why?
|
| Fasting | 1 | 2018 | 95 | 0.160 |
Why?
|
| Hypertension | 2 | 2019 | 956 | 0.150 |
Why?
|
| Nerve Net | 1 | 2019 | 123 | 0.150 |
Why?
|
| Retrospective Studies | 3 | 2015 | 3488 | 0.150 |
Why?
|
| Feedback | 1 | 2018 | 43 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 82 | 0.150 |
Why?
|
| Phenotype | 1 | 2019 | 635 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2019 | 351 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 874 | 0.150 |
Why?
|
| Education, Medical | 1 | 2018 | 68 | 0.150 |
Why?
|
| Hospitalization | 1 | 2020 | 463 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2017 | 81 | 0.150 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 57 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 73 | 0.140 |
Why?
|
| Cardiology | 1 | 2018 | 99 | 0.140 |
Why?
|
| Students, Medical | 1 | 2018 | 129 | 0.130 |
Why?
|
| Prevalence | 2 | 2015 | 979 | 0.130 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 47 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 27 | 0.120 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 27 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1527 | 0.120 |
Why?
|
| Dobutamine | 1 | 2015 | 68 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2015 | 72 | 0.120 |
Why?
|
| Prognosis | 2 | 2020 | 1498 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 106 | 0.120 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2014 | 3 | 0.120 |
Why?
|
| Exercise Test | 1 | 2015 | 225 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 43 | 0.110 |
Why?
|
| African Americans | 1 | 2020 | 1428 | 0.110 |
Why?
|
| Myocardium | 1 | 2013 | 186 | 0.110 |
Why?
|
| Brain | 1 | 2019 | 949 | 0.100 |
Why?
|
| Obesity | 1 | 2019 | 1158 | 0.100 |
Why?
|
| Abdominal Fat | 1 | 2010 | 49 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2010 | 345 | 0.070 |
Why?
|
| United States | 1 | 2015 | 3925 | 0.070 |
Why?
|
| Adult | 4 | 2020 | 9327 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 2277 | 0.060 |
Why?
|
| Age Factors | 2 | 2015 | 1187 | 0.050 |
Why?
|
| Mississippi | 1 | 2020 | 27 | 0.050 |
Why?
|
| Individuality | 1 | 2019 | 9 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 262 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 238 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 771 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1192 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 504 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 404 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 58 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 152 | 0.030 |
Why?
|
| Acute Chest Syndrome | 1 | 2014 | 1 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2014 | 6 | 0.030 |
Why?
|
| Hemolysis | 1 | 2014 | 13 | 0.030 |
Why?
|
| Iron Overload | 1 | 2014 | 38 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 461 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 34 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 662 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 764 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 593 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 899 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 378 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1514 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 449 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 388 | 0.020 |
Why?
|
| Child | 1 | 2014 | 2425 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2603 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 3511 | 0.020 |
Why?
|